News
Rocket Pharmaceuticals: Gene Therapy Pioneer On A High (NASDAQ:RCKT)
This is my first look at Rocket Pharmaceuticals (NASDAQ:RCKT). I have to say somehow it has escaped my attention over…
Credit card spending by Americans is ‘losing steam’
Americans have continued to open up their wallets and spend over the past two years, even in the face of…
Europe’s Deeptech Funding Hampered by Lack Of Understanding
In the U.K. and across Europe as a whole, those with an interest in the creation and growth of deeptech…
Altimmune: Pemvidutide Data Reinforces Obesity Drug Outlook (NASDAQ:ALT)
Altimmune (NASDAQ:ALT) has been making good progress in advancing its pipeline lately. The last time I spoke about this biotech…
What You Thought You Knew Is Hurting Your Money
Making money decisions is tricky business. There's a lot we gotta think about when we're trying to build our savings…
Aehr Test Systems: Massive Drop Created A Long-Term Opportunity
Investment Thesis Aehr Test Systems (NASDAQ:AEHR) is down over 50% in the last 3 months, which prompted me to check…
Paycom: BETI Was A Double-Edged Sword (NYSE:PAYC)
Summary Readers may find my previous coverage via this link. My previous rating was a buy, as I thought that…
IHAK ETF: Bullish Exposure To Diversified Cybersecurity Stocks
The iShares Cybersecurity and Tech ETF (NYSEARCA:IHAK) invests across a basket of companies innovating in the field of cybersecurity and…